How many days after taking one buprenorphine (Suboxone) pill can a patient start taking naltrexone (Narcan)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Waiting Period After Buprenorphine Before Starting Naltrexone

You must wait a minimum of 7-10 days after taking one buprenorphine pill before starting naltrexone to avoid precipitating severe, potentially life-threatening withdrawal. 1

FDA-Mandated Opioid-Free Interval

  • The FDA drug label explicitly requires patients to be completely opioid-free for a minimum of 7-10 days for short-acting opioids before initiating naltrexone. 1
  • Buprenorphine, despite being a partial agonist, requires the same 7-10 day washout period as other opioids. 1
  • Patients transitioning from buprenorphine may be vulnerable to precipitation of withdrawal symptoms for as long as 2 weeks, and healthcare providers should be prepared to manage withdrawal symptomatically with non-opioid medications. 1

Critical Risk of Precipitated Withdrawal

  • Administering naltrexone to patients with recent opioid exposure (including buprenorphine) can precipitate severe, potentially life-threatening withdrawal requiring hospitalization. 1
  • The FDA warns that postmarketing case reports have documented severe manifestations of precipitated withdrawal when switching from buprenorphine to naltrexone. 1
  • Starting naltrexone too early after buprenorphine can precipitate severe withdrawal because naltrexone blocks opioid receptors as a competitive antagonist, and any residual buprenorphine will be displaced from receptors. 2

Verification Before Naltrexone Initiation

  • Before starting naltrexone, perform a naloxone challenge test to confirm the patient is adequately opioid-free. 1
  • The naloxone challenge should not be performed in patients showing clinical signs of opioid withdrawal or whose urine contains opioids. 1
  • For intravenous challenge: inject 0.2 mg naloxone, observe for 30 seconds, then inject 0.6 mg if no withdrawal signs appear, and observe for an additional 20 minutes. 1
  • For subcutaneous challenge: administer 0.8 mg naloxone and observe for 20 minutes for signs of withdrawal (nausea, vomiting, sweating, pupillary dilation, anxiety, muscle aches). 1
  • If the naloxone challenge is positive (withdrawal signs appear), do not initiate naltrexone and repeat the challenge in 24 hours. 1

Clinical Algorithm

  • Confirm the patient's last dose of buprenorphine was at least 7-10 days ago. 1
  • Verify the patient has no clinical signs of opioid withdrawal and no opioids in urine. 1
  • Perform a naloxone challenge test to confirm adequate opioid-free status. 1
  • If the challenge is negative, initiate naltrexone at 25 mg on day 1, then increase to 50 mg daily if no withdrawal occurs. 1
  • If the challenge is positive, wait an additional 24 hours and repeat the challenge before attempting naltrexone initiation. 1

Common Pitfall to Avoid

  • The most dangerous error is assuming buprenorphine's partial agonist properties allow for a shorter waiting period—they do not. 1
  • Buprenorphine has a long half-life and high receptor affinity, making precipitated withdrawal particularly severe if naltrexone is started prematurely. 1
  • Extended-release naltrexone formulations require an even longer washout period of 24-30 days after the last injection if the patient later needs to restart buprenorphine. 3, 2

References

Guideline

Timing of Suboxone Initiation After Naltrexone Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.